CARES Act Fees & Submissions: What Drug Companies Can’t Afford to Miss скачать в хорошем качестве

CARES Act Fees & Submissions: What Drug Companies Can’t Afford to Miss

Get In Touch with a Regulatory Expert: https://www.registrarcorp.com/contact... Follow us on social media:   / registrar-corp     / registrarcorp   X / https://x.com/registrarcorp In this webinar, Melissa Sayers, moderated by Sofia Fernandez, broke down key updates to CARES Act fees, registration, listing, and reporting requirements that impact drug manufacturers marketing products in the U.S. The session covers: ✔ What’s changed under the CARES Act ✔ Common compliance gaps FDA is identifying ✔ Fee and submission requirements manufacturers can’t overlook ✔ Practical steps to reduce regulatory risk before entering the U.S. market If your team is responsible for registrations, listings, or regulatory strategy, this is essential viewing.